Modelling cost-effectiveness and value of information in clinical trials to inform stop go decisions: results from the arctic study

被引:0
|
作者
Smith, Alison [1 ]
Hall, Peter [2 ]
O'Dwyer, John [1 ]
Hulme, Claire [1 ]
Cohen, Dena [1 ]
Gregory, Walter [1 ]
机构
[1] Univ Leeds, York, N Yorkshire, England
[2] Univ Edinburgh, Edinburgh, Midlothian, Scotland
来源
TRIALS | 2015年 / 16卷
关键词
Chronic Lymphocytic Leukaemia; Mitoxantrone; Interim Analysis; Fludarabine; Health Loss;
D O I
10.1186/1745-6215-16-S2-O27
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
O27
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Modelling cost-effectiveness and value of information in clinical trials to inform stop go decisions: results from the arctic study
    Alison Smith
    Peter Hall
    John O'Dwyer
    Claire Hulme
    Dena Cohen
    Walter Gregory
    Trials, 16
  • [2] Optimal cost-effectiveness decisions: The role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI)
    Barton, Garry R.
    Briggs, Andrew H.
    Fenwick, Elisabeth A. L.
    VALUE IN HEALTH, 2008, 11 (05) : 886 - 897
  • [3] The cost-effectiveness of the Olweus Bullying Prevention Program: Results from a modelling study
    Beckman, Linda
    Svensson, Mikael
    JOURNAL OF ADOLESCENCE, 2015, 45 : 127 - 137
  • [4] The value of cost-effectiveness analyses for reimbursement decisions: Perspectives from medicare
    Sheingold, SH
    AMERICAN HEART JOURNAL, 1999, 137 (05) : S81 - S86
  • [5] Using cost-effectiveness results from abroad for local policy decisions
    Knies, Saskia
    Severens, J. L.
    Ament, A. J. H. A.
    Evers, Silvia M. A. A.
    EJHP PRACTICE, 2008, 14 (04): : 51 - 54
  • [6] Bayesian estimation of cost-effectiveness ratios from clinical trials
    Heitjan, DF
    Moskowitz, AJ
    Whang, W
    HEALTH ECONOMICS, 1999, 8 (03) : 191 - 201
  • [7] Clinical and cost-effectiveness of insulin degludec: from clinical trials to clinical practice
    Evans, Marc
    McEwan, Phil
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2015, 4 (03) : 279 - 286
  • [8] Cost-effectiveness of gemifloxacin: Results from the GLOBE study
    Halpern, MT
    Palmer, CS
    Zodet, M
    Kirsch, J
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (14) : 1357 - 1365
  • [9] On the probability of cost-effectiveness using data from randomized clinical trials
    Willan A.R.
    BMC Medical Research Methodology, 1 (1) : 1 - 5
  • [10] Cost-effectiveness results from the US Carvedilol Heart Failure Trials Program
    Vera-Llonch, M
    Menzin, J
    Richner, RE
    Oster, G
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (7-8) : 846 - 851